Exportar Publicação

Gil, I., Santos-Costa, P., Bobrowicz-Campos, E., Barata, A., Parola, V., Coelho, A....et al. (2021). Pilot study on the effectiveness of Reminiscence Therapy on cognition, depressive symptoms, and quality of life in nursing home residents. Translational Medicine @ UniSa. 23 (4), 82-91

I. Gil et al.,  "Pilot study on the effectiveness of Reminiscence Therapy on cognition, depressive symptoms, and quality of life in nursing home residents", in Translational Medicine @ UniSa, vol. 23, no. 4, pp. 82-91, 2021

@article{gil2021_1731964815974,
	author = "Gil, I. and Santos-Costa, P. and Bobrowicz-Campos, E. and Barata, A. and Parola, V. and Coelho, A. and et al.",
	title = "Pilot study on the effectiveness of Reminiscence Therapy on cognition, depressive symptoms, and quality of life in nursing home residents",
	journal = "Translational Medicine @ UniSa",
	year = "2021",
	volume = "23",
	number = "4",
	doi = "10.37825/2239-9747.1018",
	pages = "82-91",
	url = "https://pubmed.ncbi.nlm.nih.gov/34447721/"
}

TY  - JOUR
TI  - Pilot study on the effectiveness of Reminiscence Therapy on cognition, depressive symptoms, and quality of life in nursing home residents
T2  - Translational Medicine @ UniSa
VL  - 23
IS  - 4
AU  - Gil, I.
AU  - Santos-Costa, P.
AU  - Bobrowicz-Campos, E.
AU  - Barata, A.
AU  - Parola, V.
AU  - Coelho, A.
AU  - et al.
PY  - 2021
SP  - 82-91
SN  - 2239-9747
DO  - 10.37825/2239-9747.1018
UR  - https://pubmed.ncbi.nlm.nih.gov/34447721/
AB  - Aim: This study aimed to assess the effectiveness of the group Reminiscence Therapy (RT) on cognition, depressive symptoms, and quality of life (QOL) in older adults recruited in nursing homes.

Methods: A pilot study with a one-group pretest-posttest design was conducted between September 2017 and March 2018 in five nursing homes from central Portugal. A comprehensive RT program (Core program followed by a Follow-up program) was provided to clinically stable volunteers aged 65 years or more, who did not have severe cognitive impairment.

Results: From the 50 older adults (32 women and 18 men, with mean age of 83.32±7.76, and mean education level of 5.48±4.05) considered eligible to participate in the study, 35 (mean age: 84.17±7.46, mean education level of 6.14±4.49) completed the Core Program and 28 completed the Follow-up Program (mean age: 84.25±7.66, mean education level of 6.18±4.57). Based on the Wilcoxon Test, it was observed that the participants' cognitive performance did not change during the two RT programs. No significant changes were confirmed in relation to depressive symptomatology and QOL.

Conclusion: Although no statistically significant improvements of the older adults' cognitive function, depressive symptomatology, and quality of life were found, the stabilization of such outcomes are relevant from a clinical viewpoint. Further studies are necessary to confirm these findings.

ER  -